Study of TTX-MC138 in Subjects With Advanced Solid Tumors
Clinical trial NCT06260774 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06260774
- Sponsor
- TransCode Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-05
- Primary completion
- 2025-09-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.